Log in
Psychiatry · Chapter 17. Therapy of Mental Disorders. Basic Principles of Prevention and Rehabilitation

Tranquilizers

Anxiolytica

Tranquilizers are a group of psychotropic medications that are used in psychopharmacotherapy not only for their primary indications, but also as an essential tool for managing neurological complications. Specifically, benzodiazepine tranquilizers are the drugs of choice in emergency conditions and specific movement disorders induced by other medications.

GroupBenzodiazepine tranquilizers
Emergency careManagement of acute spasms (dystonia)
Complex therapyTreatment of tardive dyskinesia in combination with other agents
4 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

The role of tranquilizers in the management of extrapyramidal disorders

In clinical psychiatric practice, benzodiazepine tranquilizers play a crucial role in treatment regimens for neurological side effects caused by antipsychotics. These complications, known as extrapyramidal symptoms, require prompt and appropriate intervention.

Benzodiazepines are used in situations where it is necessary to suppress excessive motor activity or pathological muscle tone. Unlike antidepressants, which require a delayed onset of action (at least 10–15 days), tranquilizers are capable of exerting a rapid effect, which is critically important in urgent situations.

Use in acute spasms (dystonia)

Acute spasms, or dystonia, are a severe neurological complication that develops during antipsychotic therapy. To prevent this condition, a slow dose escalation of the primary drug and frequent divided dosing are recommended.

If acute dystonia has already developed, the patient requires emergency care. This comprehensive management necessarily includes:

  • Benzodiazepine tranquilizers;
  • Biperiden (akineton) injections;
  • Metoclopramide.

Rapid administration of tranquilizers effectively relieves acute muscle spasms and improves the patient's condition.

Test your knowledge on the topicTasks from the "Psychiatry" course bank — immediate answers and explanations.

Treatment of tardive dyskinesia

Tardive dyskinesia is a persistent disorder manifested by hyperkinesia of the face and head (e.g., involuntary chewing, lip smacking, or frequent blinking).

The pathogenesis of this condition is associated with a compensatory upregulation of central nervous system sensitivity to dopamine, leading to the formation of additional receptors. A specific feature of tardive dyskinesia is that upon discontinuation of the offending antipsychotic, the symptoms do not disappear; rather, they worsen.

A combined approach is used to treat tardive dyskinesia. Benzodiazepine tranquilizers are prescribed in combination with the following drug classes:

  1. Beta-blockers;
  2. Nootropics;
  3. Sedative antidepressants.

Risk factors for this complication that may warrant the prescription of tranquilizers include long-term antipsychotic therapy (6 months or longer), age over 40, female sex, and a history of organic CNS damage.

Place of tranquilizers among other psychotropic agents

The mechanisms of action of various psychotropic drugs differ significantly. Thus, tranquilizers are aimed at rapidly relieving anxiety and spasms, whereas, for example, antidepressants alleviate persistent depressed mood by potentiating monoamine neurotransmitter systems in the brain (norepinephrine, serotonin, and dopamine).

It is important to remember that any psychopharmacotherapy requires caution. For instance, the prescription of correctors for drug-induced parkinsonism excludes the use of levodopa (as it may provoke a psychotic exacerbation), and discontinuation of MAO inhibitors requires waiting at least two weeks before prescribing other psychotropic medications to avoid dangerous interactions. When choosing any treatment regimen involving tranquilizers or other agents, it is essential to consider the adverse effect profile and individual patient risks.

Briefly: answers to topical questions

Which specific benzodiazepine tranquilizers are used to manage extrapyramidal disorders?

Diazepam is specifically indicated for the management of extrapyramidal disorders: in poisonings, it is used as a muscle relaxant for severe muscle rigidity, parkinsonism, and acute dystonia. For acute spasms and tardive dyskinesia, sources indicate the use of benzodiazepine tranquilizers as a class, without specifying individual drugs. For akathisia, sources indicate anticholinergics and beta-blockers.

What clinical manifestations are characteristic of tardive dyskinesia?

Tardive dyskinesia is characterized by persistent involuntary movements—hyperkinesia of the face and head, including chewing, lip smacking, and blinking. They do not disappear after antipsychotic discontinuation, but rather worsen.

What is the mechanism of action of benzodiazepine tranquilizers at the receptor level?

Benzodiazepine tranquilizers bind to specific allosteric benzodiazepine receptors that are part of the GABA-A receptor complex and are distinct from the GABA binding site. This causes allosteric modulation of the GABA-A complex, increases the frequency of chloride channel opening, and leads to neuronal membrane hyperpolarization and an inhibitory effect.

What side effects are characteristic of benzodiazepine tranquilizers?

Benzodiazepine tranquilizers are characterized by dizziness, headache, drowsiness, and ataxia. Long-acting agents may also cause prolonged drowsiness, lethargy, dizziness, ataxia, and memory impairment. Long-term use carries a high risk of dependence. Withdrawal can cause increased anxiety, insomnia, seizures, and hypnagogic hallucinations; delirium is rare. In elderly patients, due to reduced clearance rates, there is an increased likelihood of drug accumulation and risk of overdose symptoms, including muscle weakness and ataxia.

Class and exam questions

In what emergency cases are benzodiazepine tranquilizers used?

They are used for emergency relief of acute spasms (dystonias) developing as a side effect of neuroleptic therapy.

Do tranquilizers help with tardive dyskinesia?

Yes, benzodiazepine tranquilizers are included in the treatment regimen for tardive dyskinesia along with beta-blockers, nootropics, and sedative antidepressants.

Can a tranquilizer be replaced with levodopa in extrapyramidal disorders?

No, levodopa is strictly contraindicated, as it can provoke a psychotic exacerbation in the patient.

Something unclear? Ask the AIThe AI tutor has read the material on "Tranquilizers" and will explain it in simple terms.

What else to study on this topic

  • Drug-induced parkinsonism and correctors (anticholinergics)
  • Neuroleptic malignant syndrome (NMS) and emergency resuscitation
  • Specifics of sedative antidepressants in the treatment of dyskinesia
  • Anticholinergic effects of psychotropic medications
  • Mechanisms of tardive dyskinesia development (dopamine receptors)

Master the entire topic in the "Psychiatry" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Tranquilizers" and 499 other pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 7 video lessons on the subject

Other topics in "Chapter 17. Therapy of Mental Disorders. Basic Principles of Prevention and Rehabilitation"

The entire section "Chapter 17. Therapy of Mental Disorders. Basic Principles of Prevention and Rehabilitation"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.